[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542093":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":54,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"Power Life Sciences Inc.","INDUSTRY",null,[9],{"name":10,"affiliation":5,"role":11},"Michael B Gill","STUDY_DIRECTOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","415-900-4227","bask@withpower.com",[18],{"facility":19,"status":7,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Power Life Sciences","San Francisco","California","94107","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-122.41942,37.77493,{"lat":29,"lon":28},[32],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":33},"https:\u002F\u002Fwww.withpower.com\u002Fcontact-us@withpower.com",{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100542093","examining-engagement-trends-among-participants-in-peripheral-neuropathy-clinical-research-100542093",false,"NCT06338384","Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research","A Study of Peripheral Neuropathy Clinical Trial Experiences: Insights From Patients","Inclusion Criteria:\n\n* Aged ≥ 18 years old\n* Diagnosis of peripheral neuropathy\n* Able to comprehend the investigational nature of the protocol and provide informed consent\n\nExclusion Criteria:\n\n* Female patients who are currently pregnant or nursing\n* Inability to perform regular electronic reporting\n* Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial","ALL","18 Years",{"count":46,"type":47},500,"ESTIMATED","OBSERVATIONAL","This trial aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in peripheral neuropathy clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.\n\nUltimately, this trial endeavors to deepen our understanding of the factors impacting peripheral neuropathy clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.",[51],"Peripheral Neuropathy",[53],"peripheral neuropathy","NOT_YET_RECRUITING","2024-03-22",{"date":57,"type":58},"2024-03-29","ACTUAL",{"date":60,"type":47},"2025-04",{"date":62,"type":47},"2027-04",{"name":5,"class":6},1]